Understanding the Market | BAIYUNSHAN PH rose over 4% after earnings, with net profit attributable to shareholders for the first three quarters at 3.31 billion yuan; its Wanglaoji International can product has debuted in the Middle East market

BAIYUNSHAN PH rose over 4% after earnings, as of the time of writing, up 4.61%, reported at HKD 18.85, with a trading volume of HKD 58.3307 million. On the news front, on October 28, BAIYUNSHAN announced its performance for the first three quarters of 2025, with the group achieving operating revenue of CNY 61.606 billion, an increase of 4.31% year-on-year; net profit attributable to shareholders of the listed company was CNY 3.31 billion, an increase of 4.78% year-on-year; basic earnings per share were CNY 2.036. It is worth mentioning that recently, the Fortune Global Forum opened in Riyadh, the capital of Saudi Arabia. BAIYUNSHAN's Wanglaoji Health was invited to attend and held the Wanglaoji WALOVI international can listing ceremony in Saudi Arabia during the forum. It is reported that after launching the "WALOVI" English brand logo in Saudi Arabia in February this year, Wanglaoji's international can officially listed in Saudi Arabia, marking the first entry of this product series into the Middle Eastern market and representing a key step in Wanglaoji's globalization strategy in the Middle East